North American governments seem more keen on legalizing marijuana for recreational purposes than promoting its medical value. That’s because with drug patents, there are huge profits to be made and incentives for the pharmaceutical industry to invest in research and to lobby governments. But you cannot patent a plant. Fortunately, there are those who are making slow progress in the fight for medical marijuana research.
Cannabis has been proven to be very effective for the treatment of glaucoma, HIV/AIDS-related weight loss, cachexia associated with cancer, nausea due to chemotherapy, spasticity and tremors of MS, neuropathic pain of type 1 and 2 diabetes and HIV, insomnia, anxiety, epilepsy, rheumatism, PTSD and pain.
Pain afflicts so many. Yet the pharmaceutical industry, or Big Pharma, can only offer NSAIDS, which cause stomach ulcers, liver and kidney damage and increased risk of heart attacks and strokes —or opioids that are highly damaging and addictive. Cannabis brings none of these side effects. Neuropathic pain is on the rise because of the epidemic number of diabetic patients. All that Big Pharma can offer is insulin and other drugs that control blood glucose levels, but once you develop neuropathic pain, you are stuck. This is where cannabis can save the day.
With the stress of hectic lifestyles comes increased insomnia. It is associated not only with weight gain, daytime fogginess, agitation and lack of concentration but also with increased risk of heart disease. Cannabis can treat this without the risks.
As for the paranoid, anxious, or a detached feeling some get from marijuana, this is the recreational component called THC. CBD strains contain a therapeutic compound that counteracts the unwanted effects of THC. That’s all for now on the topic of medical marijuana. I’ll tackle this topic again soon.